290 related articles for article (PubMed ID: 15642678)
1. How we treat Waldenström's macroglobulinemia.
Dimopoulos MA; Merlini G; Leblond V; Anagnostopoulos A; Alexanian R
Haematologica; 2005 Jan; 90(1):117-25. PubMed ID: 15642678
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of Waldenstrom's macroglobulinemia.
Dimopoulos MA; Kyle RA; Anagnostopoulos A; Treon SP
J Clin Oncol; 2005 Mar; 23(7):1564-77. PubMed ID: 15735132
[TBL] [Abstract][Full Text] [Related]
3. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
[TBL] [Abstract][Full Text] [Related]
4. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.
Dimopoulos MA; Gertz MA; Kastritis E; Garcia-Sanz R; Kimby EK; Leblond V; Fermand JP; Merlini G; Morel P; Morra E; Ocio EM; Owen R; Ghobrial IM; Seymour J; Kyle RA; Treon SP
J Clin Oncol; 2009 Jan; 27(1):120-6. PubMed ID: 19047284
[TBL] [Abstract][Full Text] [Related]
5. Waldenström's macroglobulinemia.
Dimopoulos MA; Anagnostopoulos A
Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
[TBL] [Abstract][Full Text] [Related]
6. Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM).
Anagnostopoulos A; Giralt S
Bone Marrow Transplant; 2002 Jun; 29(12):943-7. PubMed ID: 12098060
[TBL] [Abstract][Full Text] [Related]
7. Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: review of the literature and future directions.
Anagnostopoulos A; Aleman A; Giralt S
Semin Oncol; 2003 Apr; 30(2):286-90. PubMed ID: 12720154
[TBL] [Abstract][Full Text] [Related]
8. Rituximab-based treatments in Waldenström's macroglobulinemia.
Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
[TBL] [Abstract][Full Text] [Related]
9. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
[TBL] [Abstract][Full Text] [Related]
10. Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstrom's macroglobulinemia.
Munshi NC; Barlogie B
Semin Oncol; 2003 Apr; 30(2):282-5. PubMed ID: 12720153
[TBL] [Abstract][Full Text] [Related]
11. Waldenström's macroglobulinemia.
McKenna JA
Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Waldenstrom's Macroglobulinemia.
Dimopoulos MA; Anagnostopoulos A
Curr Treat Options Oncol; 2007 Apr; 8(2):144-53. PubMed ID: 17634838
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapies in Waldenström macroglobulinemia.
Burwick N; Roccaro AM; Leleu X; Ghobrial IM
Curr Opin Investig Drugs; 2008 Jun; 9(6):631-7. PubMed ID: 18516762
[TBL] [Abstract][Full Text] [Related]
15. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
16. Waldenström macroglobulinaemia.
Fonseca R; Hayman S
Br J Haematol; 2007 Sep; 138(6):700-20. PubMed ID: 17672883
[TBL] [Abstract][Full Text] [Related]
17. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
[TBL] [Abstract][Full Text] [Related]
18. Waldenström's macroglobulinemia: a review of therapy.
Gertz MA
Leuk Lymphoma; 2002 Aug; 43(8):1517-26. PubMed ID: 12400593
[TBL] [Abstract][Full Text] [Related]
19. Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide.
Dimopoulos MA; Anagnostopoulos A; Kyrtsonis MC; Zervas K; Tsatalas C; Kokkinis G; Repoussis P; Symeonidis A; Delimpasi S; Katodritou E; Vervessou E; Michali E; Pouli A; Gika D; Vassou A; Terpos E; Anagnostopoulos N; Economopoulos T; Pangalis G
J Clin Oncol; 2007 Aug; 25(22):3344-9. PubMed ID: 17577016
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of Waldenström's macroglobulinemia.
Johnson SA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):329-34. PubMed ID: 16503850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]